Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma

T. Y. Chao, H. Ohnishi, T. M. Chu

研究成果: 雜誌貢獻文章

9 引文 (Scopus)

摘要

The effect of mouse recombinant interferon-gamma (rIFN-γ) on murine lymphokine-activated killer (LAK) cell activity was investigated using natural killer (NK)-resistant, spontaneously developed, weakly immunogenic and highly tumourigenic, syngeneic murine mammary adenocarcinoma, JC, mimicking that of human disease, as the target. Murine YAC-1 also was used as a target cell line. rIFN-γ, when used in combination with recombinant interleukin-2 (rIL-2), was shown to exhibit a suppressed effect on LAK cell activity generated from BALB/c mouse splenocytes, compared to that with rIL-2 alone. The decrease in LAK cell activity was rIFN-γ dose-dependent. Kinetic study revealed that this inhibitory effect was demonstrated when rIFN-γ was added to the medium at the early phase of rIL-2 culture. The inhibitory effect on LAK cell generation by rIFN-γ was completely abrogated when the nylon-wool-treated non-adherent 'macrophage-free' splenocytes were incubated with rIL-2 and rIFN-γ. These results indicated that the LAK cell activity generated from murine splenocytes cultured with rIL-2 could be depressed by rIFN-γ, and that the macrophages may be involved as mediators.

原文英語
頁(從 - 到)116-120
頁數5
期刊Immunology
70
發行號1
出版狀態已發佈 - 1990
對外發佈Yes

指紋

Lymphokine-Activated Killer Cells
Interferon-gamma
Interleukin-2
Macrophages
Wool
Nylons
Adenocarcinoma
Breast
Cell Line

ASJC Scopus subject areas

  • Immunology

引用此文

Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma. / Chao, T. Y.; Ohnishi, H.; Chu, T. M.

於: Immunology, 卷 70, 編號 1, 1990, p. 116-120.

研究成果: 雜誌貢獻文章

@article{304f90303b8f422d87d8dd8f1e73eafa,
title = "Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma",
abstract = "The effect of mouse recombinant interferon-gamma (rIFN-γ) on murine lymphokine-activated killer (LAK) cell activity was investigated using natural killer (NK)-resistant, spontaneously developed, weakly immunogenic and highly tumourigenic, syngeneic murine mammary adenocarcinoma, JC, mimicking that of human disease, as the target. Murine YAC-1 also was used as a target cell line. rIFN-γ, when used in combination with recombinant interleukin-2 (rIL-2), was shown to exhibit a suppressed effect on LAK cell activity generated from BALB/c mouse splenocytes, compared to that with rIL-2 alone. The decrease in LAK cell activity was rIFN-γ dose-dependent. Kinetic study revealed that this inhibitory effect was demonstrated when rIFN-γ was added to the medium at the early phase of rIL-2 culture. The inhibitory effect on LAK cell generation by rIFN-γ was completely abrogated when the nylon-wool-treated non-adherent 'macrophage-free' splenocytes were incubated with rIL-2 and rIFN-γ. These results indicated that the LAK cell activity generated from murine splenocytes cultured with rIL-2 could be depressed by rIFN-γ, and that the macrophages may be involved as mediators.",
author = "Chao, {T. Y.} and H. Ohnishi and Chu, {T. M.}",
year = "1990",
language = "English",
volume = "70",
pages = "116--120",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma

AU - Chao, T. Y.

AU - Ohnishi, H.

AU - Chu, T. M.

PY - 1990

Y1 - 1990

N2 - The effect of mouse recombinant interferon-gamma (rIFN-γ) on murine lymphokine-activated killer (LAK) cell activity was investigated using natural killer (NK)-resistant, spontaneously developed, weakly immunogenic and highly tumourigenic, syngeneic murine mammary adenocarcinoma, JC, mimicking that of human disease, as the target. Murine YAC-1 also was used as a target cell line. rIFN-γ, when used in combination with recombinant interleukin-2 (rIL-2), was shown to exhibit a suppressed effect on LAK cell activity generated from BALB/c mouse splenocytes, compared to that with rIL-2 alone. The decrease in LAK cell activity was rIFN-γ dose-dependent. Kinetic study revealed that this inhibitory effect was demonstrated when rIFN-γ was added to the medium at the early phase of rIL-2 culture. The inhibitory effect on LAK cell generation by rIFN-γ was completely abrogated when the nylon-wool-treated non-adherent 'macrophage-free' splenocytes were incubated with rIL-2 and rIFN-γ. These results indicated that the LAK cell activity generated from murine splenocytes cultured with rIL-2 could be depressed by rIFN-γ, and that the macrophages may be involved as mediators.

AB - The effect of mouse recombinant interferon-gamma (rIFN-γ) on murine lymphokine-activated killer (LAK) cell activity was investigated using natural killer (NK)-resistant, spontaneously developed, weakly immunogenic and highly tumourigenic, syngeneic murine mammary adenocarcinoma, JC, mimicking that of human disease, as the target. Murine YAC-1 also was used as a target cell line. rIFN-γ, when used in combination with recombinant interleukin-2 (rIL-2), was shown to exhibit a suppressed effect on LAK cell activity generated from BALB/c mouse splenocytes, compared to that with rIL-2 alone. The decrease in LAK cell activity was rIFN-γ dose-dependent. Kinetic study revealed that this inhibitory effect was demonstrated when rIFN-γ was added to the medium at the early phase of rIL-2 culture. The inhibitory effect on LAK cell generation by rIFN-γ was completely abrogated when the nylon-wool-treated non-adherent 'macrophage-free' splenocytes were incubated with rIL-2 and rIFN-γ. These results indicated that the LAK cell activity generated from murine splenocytes cultured with rIL-2 could be depressed by rIFN-γ, and that the macrophages may be involved as mediators.

UR - http://www.scopus.com/inward/record.url?scp=0025236647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025236647&partnerID=8YFLogxK

M3 - Article

C2 - 2113034

AN - SCOPUS:0025236647

VL - 70

SP - 116

EP - 120

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 1

ER -